Related Experiment Videos
Perioperative management of patients with myasthenia gravis: prevention, recognition, and treatment
1Oral And Maxillofacial Surgery Department, Thomas Jefferson University Hospital, USA. basem_jamal@yahoo.com
Abstract:
Myasthenia gravis (MG) is an autoimmune disease characterized by weakness and fatigability of skeletal muscles, with improvement following rest. The disease was so named because of a frequently fatal outcome. As recently as 30 years ago, 25% of patients with MG died of the disease. Treatment advances have dramatically changed the expected outcome, and with appropriate therapy, most patients with MG can now lead normal lives and have a relatively normal life expectancy. In this article we review the pathophysiology of MG, its signs and symptoms, treatment, the perioperative evaluation and preparation for surgery, and the anesthetic consideration to enable clinicians better understand this disease entity and provide guidance in diagnosis and care of patients with MG.
Insights
Myasthenia gravis (MG) is an autoimmune neuromuscular disease causing muscle weakness. Advances in treatment have significantly improved outcomes, allowing most patients to lead normal lives with appropriate care.
Area of Science:
- Neurology
- Immunology
- Autoimmune Diseases
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Historically, MG had a high mortality rate, with 25% of patients dying from the disease 30 years ago.
- Significant treatment advancements have transformed the prognosis for MG patients.
Purpose of the Study:
- To provide a comprehensive review of myasthenia gravis.
- To enhance clinician understanding of MG pathophysiology, diagnosis, and management.
- To guide perioperative care and anesthetic considerations for patients with MG.
Main Methods:
- Review of current literature on myasthenia gravis.
- Synthesis of information on pathophysiology, clinical presentation, and treatment.
- Analysis of perioperative and anesthetic management strategies.
Main Results:
- Most patients with MG can now achieve normal lives with appropriate therapy.
- Treatment advances have dramatically improved the expected outcome and life expectancy.
- Understanding pathophysiology and management is key to optimal patient care.
Conclusions:
- Myasthenia gravis management has evolved, offering improved quality of life.
- Comprehensive knowledge of MG is crucial for effective clinical practice.
- This review provides essential guidance for diagnosing and treating MG patients.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:22Myasthenia Gravis ll: Pathophysiology
01:22Myocarditis IV: Nursing Management
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...